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ABSTRACT
Mammary gland is an organ that undergoes cycles of growth, dif-
ferentiation, and function during pregnancy and lactation. Although
it is known that the gland enhances its sensitivity to insulin during
lactation, it remains to be investigated whether this increased sen-
sitivity develops during pregnancy and which are the molecular mech-
anisms underlying such a change. To address this issue, virgin and
late-pregnant rats were subjected to a continuous infusion with 50%
glucose for 72 h to produce a prolonged hyperinsulinemic-euglycemic
condition. Insulin sensitivity in mammary gland was determined as
the glucose utilization index by using 2-[3H]-deoxyglucose. Further-
more, binding characteristics and kinase activity were studied by
means of both [125I]insulin binding and in vitro phosphorylation stud-
ies with insulin receptors partially purified from mammary gland.
Whereas the glucose utilization index in mammary gland from
nonpregnant rats remained unaffected by hyperinsulinemia, glands
from pregnant rats displayed a high insulin-dependent glucose up-
take. This effect was not paralleled by changes in the binding char-
acteristics of insulin to the high-affinity receptor, suggesting that the
high insulin sensitivity of mammary gland in pregnancy is not ac-
counted for by changes at the level of hormone-receptor interaction.
Autophosphorylation studies showed that insulin-stimulated kinase
activity of insulin receptors from mammary gland was 6- and 20-fold
higher in pregnant than in virgin animals under normo- and hyper-
insulinemic conditions, respectively. Moreover, insulin dose-response
curves revealed that the efficacy of insulin to stimulate kinase activity
of the insulin receptor was markedly higher in pregnant than in virgin
rats, whereas its potency (ED50 ; 15 nM) was not changed. These data,
therefore, show that mammary glands develop increased insulin sen-
sitivity during late pregnancy, caused by an augmented kinase ac-
tivity of the insulin receptor. (Endocrinology 139: 520–526, 1998)
LATE pregnancy is characterized by the development ofinsulin resistance in both humans (1–3) and rats (4–6).
Among the tissues that most actively contribute to the re-
duced insulin sensitivity are adipose tissue (4, 7) and skeletal
muscle (8, 9). Whereas adipose tissue remains insulin-resis-
tant during lactation (10), lactating mammary gland becomes
highly sensitive to insulin (11–13). This enhanced mammary
gland insulin sensitivity is rapidly abolished on weaning
(12), but nothing is known about insulin responsiveness in
the late-pregnancy mammary tissue.
The mammary gland in late pregnancy is characterized by
alveolar morphogenesis, disappearance of adipose cells, and
structural and functional differentiation of alveolar epithelial
cells, enabling them to secrete milk fat and protein during
lactation (14, 15). This development and differentiation of the
rat mammary gland are further accompanied by changes in
the expression of glucose transporters. Whereas in mammary
gland of virgin rats, the insulin sensitive isoform of the glu-
cose transporter Glut4 predominates (16), during late preg-
nancy, expression of Glut4 decreases and is abolished in the
lactating mammary tissue (14, 16). Furthermore, lipoprotein
lipase activity increases during late pregnancy (17), reaching
a maximum during lactation (18). Thus, the morphological
and functional changes characteristic for the lactating and
mature mammary gland apparently start to develop already
during pregnancy. Therefore, the present study was de-
signed to clarify whether the increased insulin sensitivity of
mammary gland observed in lactation does develop during
pregnancy. To address this issue, virgin and pregnant rats
were exposed to a continuous iv infusion with glucose that
has been already shown to induce hyperinsulinemia (HI)
unaccompanied by hypoglycemia (19, 20). In these animals,
insulin sensitivity was assessed using the euglycemic-hy-
perinsulinemic clamp, and glucose utilization in the mam-
mary gland was quantified by means of the 2-deoxyglucose
(2-DOG) technique. These experiments revealed that mam-
mary gland tissue becomes insulin sensitive during preg-
nancy. To further investigate the molecular mechanism un-
derlying the increased responsiveness of the tissue, the study
was extended to determine whether the interaction of insulin
with its receptor and/or the insulin receptor kinase activity
are affected during pregnancy under basal or hyperinsuline-
mic conditions, by means of radioligand binding and in vitro
phosphorylation studies. Finally, insulin-dependent auto-
phosphorylation of the receptors was correlated with the
insulin responsiveness of the mammary gland, providing
evidence for the involvement of increased receptor kinase
activity in the enhanced insulin sensitivity of mammary
gland during late pregnancy.
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Female Wistar rats were housed at 22–24 C, with light cycles from
0800 to 2000 h. They had free access to water and to a chow diet (Letica,
Barcelona, Spain). Some animals were mated when they weighed 170–
180 g. The beginning of pregnancy was determined by the presence of
spermatozoids in vaginal smears. In pregnant rats at day 17 of gestation
and in age-matched virgin rats, a SILASTIC brand catheter (Dow Corn-
ing, Midland, MI, 0.02 inch ID, 0.037 inch OD) was placed into the right
jugular vein and another one into the right femoral vein, under ketamine
cocktail anesthesia (ketamine, 50 mg/ml; diazepan, 5 mg/ml; and at-
ropine, 1 mg/ml; 5/4/1, vol/vol/vol). After recovery from anesthesia,
animals were housed in individual cages and continuously infused for
72 h with either bidistilled water or 50% glucose, through the catheter
placed into the jugular vein, at the rate of 35 ml/day. Other method-
ological details have been previously described (19, 20). At the end of
the 72-h infusion period, some animals from each group were decapi-
tated, blood was collected from the neck wound, and mammary glands
rapidly dissected and placed in liquid nitrogen, to be stored at 280 C
until processed for insulin receptor studies, as described below. The
experimental protocol was approved by the Animal Research Commit-
tee of the Faculty of Experimental Sciences, University San Pablo-CEU.
Studies of insulin resistance
Euglycemic clamp studies in the conscious rat. A number of rats from each
group were subjected to an euglycemic- hyperinsulinemic clamp to test
the insulin sensitivity state of the animals, as described before (20). In
brief, after the 72-h infusion, blood samples were obtained from the tail
tips for determination of blood glucose (21) and plasma insulin (22). The
catheter placed in the jugular vein was connected to a two-way inter-
connector that received flow from two different infusion pumps (Pre-
cidor Infusion Pump Type 5003, Infors HT, Denkendorf, Germany).
Human insulin (Actrapid monocomponent, Novo, Copenhagen, Den-
mark) was infused, by means of one pump at a constant rate of 16 ml/min
(0.8 IU 3 h21 3 kg 21), for 60 min. Glucose infusion (20%) was given
at a variable rate through the other pump via the same catheter, to
maintain the blood glucose concentration constant at basal levels. A
steady-state glucose infusion was normally achieved within 30 min after
starting the clamp experiment. A few additional blood samples (200 ml)
were collected to determine the insulin concentration (22) at the steady-
state. The glucose disposal rate (M) was estimated as the rate of glucose
infusion at the steady-state normalized to the body weight. The insulin
sensitivity index (Sip), proposed by Ader and Bergman (23), was mea-
sured as described (19, 20).
Estimate of glucose utilization index (GUI) in mammary gland. The method
of Sokoloff et al. (24), developed for the brain, was adapted for the
unrestrained rat (19). Briefly, 2-deoxy-d-[1-3H]glucose (2-DOG; 18.3 Ci/
mmol, from Amersham, Buckinghamshire, UK) was administered, as a
bolus (30 mCi) through the catheter placed in the jugular vein, to virgin
and pregnant rats: 1) at the end of a 72-h infusion with bidistilled water
(basal group); 2) after 1 h of an euglycemic-hyperinsulinemic clamp,
subsequent to a 72-h infusion with bidistilled water (1-h hyperinsuline-
mic group); or 3) at the end of a 72-h infusion with 50% glucose (72-h
hyperinsulinemic group). In the 1-h hyperinsulinemic group, the clamp,
i.e. insulin and 20% glucose infusions, was maintained until death. Blood
samples (50 ml) were collected from the catheter placed in the femoral
vein at 1, 2, 5, 7, 10, 20, 30, 45, and 60 min after the 2-DOG administration.
Blood was deproteinized (25), and glucose concentrations (21) and
2-DOG radioactivity were determined in the supernatants. After the last
blood collection, animals were decapitated, and blood was collected
from the neck wound for plasma insulin determination (22). Mammary
gland tissue was immediately dissected and immersed in 0.5 ml of 1 m
NaOH to determine its content of 2-DOG-6-phosphate (26) and to es-
timate the GUI, as previously described (19).
Studies with insulin receptors
Preparation of partially purified insulin receptors. Pools of mammary gland
from each group (7–11 g) were homogenized in 3 vol of 25 mm Tris-HCl
(pH 7.4) buffer, containing 0.3 m sucrose, 7 mm EDTA, 50 mm NaF, 10
mm sodium pyrophosphate, 1.3 mm phenylmethylsulfonyl fluoride
(PMSF), 2 mg/ml bacitracin, and 0.3 mg/ml trypsin inhibitor. After
centrifugation at 3,000 3 g for 15 min, the supernatant was centrifuged
at 50,000 3 g for 1 h. The microsomal pellet was resuspended in 50 mm
Tris-HCl (pH 7.4) buffer, containing 150 mm NaCl and 1 mm PMSF, and
stored at 270 C. Microsomes (500 ml) were solubilized for 1 h in 2 ml
of 25 mm Tris-HCl (pH 7.4) buffer, containing 1% Triton-X-100, 4 mm
EDTA, 7 mm sodium pyrophosphate, 30 mm NaF, 0.6 mg/ml benza-
midine, 0.3 mg/ml trypsin inhibitor, 2.5 mg/ml bacitracin, and 1.3 mm
PMSF. Insoluble material was removed by centrifugation at 150,000 3
g for 1 h, and the clear supernatant was diluted 1:5 with 50 mm Tris-HCl
(pH 7.4), containing 0.05% Triton-X-100, 100 mm NaCl, 2.5 mm KCl, and
1 mm CaCl2, added to 0.5 ml of wheat germ agglutinin-Sepharose (WGA-
Sepharose, Pharmacia, Uppsala, Sweden) and rotated end-over-end for
2 h at room temperature. The WGA-Sepharose was then washed five
times with 20 vol of the same buffer, and receptors were eluted by the
addition of 500 ml of 0.3 m N-acetyl-glucosamine in the same buffer. The
protein concentration was measured (27) in these fractions and always
ranged between 0.2 and 0.4 mg/ml.
Binding to solubilized receptors. Aliquots (10 ml) of the WGA-Sepharose
eluates were incubated overnight at 4 C, with [125I-TyrA14]insulin (100
pm, from Amersham) and various concentrations of human monocom-
ponent insulin (0.16–1600 nm) in a final vol of 500 ml. After incubation,
receptor-hormone complexes were separated from free insulin by 10%
polyethylene glycol precipitation, and measurement of the bound hor-
mone was done as previously described (28). Insulin binding constants
[equilibrium dissociation constants (Kd) and maximal binding constants
(Bmax)] were estimated by Scatchard analysis.
Autophosphorylation of solubilized receptors. Aliquots (10–15 mg of protein)
of WGA-Sepharose purified insulin receptors were incubated at room
temperature for 2 h in the N-acetyl-glucosamine buffer supplemented
with increasing amounts of porcine insulin (Sigma, 0–160 nm). Phos-
phorylation assays were carried out at 0 C in the presence of [g-32P]ATP,
as previously described (29). Briefly, the phosphorylation reaction was
initiated by adding 50 mm [g-32P]ATP (specific radioactivity ;3300 cpm/
pmol), 12 mm MgCl2, 6 mm MnCl2, and 1 mm sodium orthovanadate
(final concentrations), to give a final vol of 80 ml. After a 15-min incu-
bation, the reaction was ended by applying 80 ml of a 50 mm Tris-HCl
(pH 7.4), containing 20 mm EDTA, 20 mm sodium pyrophosphate, 1 mm
ATP, 1 mm sodium orthovanadate, and 1 mm dithiothreitol. Insulin
receptors were quantitatively immunoprecipitated with antiphospho-
tyrosine antibodies prepared as in (30). After immobilization on Protein
A (Sigma Chemical Co., St. Louis, MO), the pellets were washed three
times with 50 mm TripH 7.4 (containing 0.1% SDS, 0.1% Triton-X-100,
and 0.15 m NaCl), and proteins were separated by SDS-PAGE (7%
acrylamide). Radioactive proteins were identified by autoradiography,
and the 32P-incorporation into the insulin receptor b-subunit was quan-
tified by densitometric scanning.
Statistical analysis
Statistical comparisons were made with ANOVA, followed by the
Tuckey test, or by a multiple linear-regression analysis with a 95%
confidence interval, using the Systat program (Systat, Inc., Evanston, IL).
Results are expressed as means 6 sem.
The Kd and Bmax were calculated using the nonlinear regression
fitting option of the Sigma Plot Program (Jandel Scientific Corp., San
Rafael, CA).
Results
Model of the euglycemic-hyperinsulinemic rat
Body weight, circulating components. In the present study, to
investigate the response of mammary glands to insulin in late
pregnancy, an animal model of prolonged iv glucose infu-
sion in the rat, to attain hyperinsulinemia under euglycemic
conditions, was used (19, 20). Virgin and pregnant rats (17
day of gestation) were subjected to a continuous infusion
with bidistilled water (control) or 50% glucose for 72 h.
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Animals within each group were of equal weight at the
beginning of the infusion and, as shown in Table 1, 50%
glucose treatment for 72 h did not affect the body weight of
either virgin or pregnant rats. Blood glucose levels were
lower in pregnant than in virgin rats and remained the same
upon glucose infusion in both groups. Plasma insulin levels
were higher in pregnant than in virgin rats, but both groups
responded similarly to glucose treatment with a 2- to 3-fold
increase in plasma insulin concentration (Table 1). These
data, therefore, show that the model of glucose infusion for
3 days is suitable to generate hyperinsulinemic-euglycemic
conditions, both in virgin and pregnant rats.
Euglycemic-hyperinsulinemic clamp. To determine how the glu-
cose infusion affected insulin sensitivity, an euglycemic-hy-
perinsulinemic clamp (0.8 IU insulin 3 h21 3 kg 21) was
performed for 60 min in unrestrained virgin and pregnant
rats at the end of the 72-h infusion with either 50% glucose
or bidistilled water. Under these conditions, blood glucose
remained stable, whereas plasma insulin increased in the
four groups (Table 2) when compared with the basal values
before the clamp (Table 1). Plasma insulin concentrations
during the clamp were higher in the groups receiving the
50% glucose infusion than in their respective controls, and in
pregnant than in virgin rats (Table 2). In virgin animals, 72 h
of 50% glucose infusion resulted in a significant decrease in
both the M and the Sip, by 39% and 43%, respectively, show-
ing the development of insulin resistance under hyperinsu-
linemic-euglycemic conditions (Table 2). Pregnant control
animals clearly exhibited insulin resistance, as evidenced by
their low M and Sip-values (41% and 55% of virgin controls,
respectively). In contrast to virgin animals, in pregnant rats,
72 h of 50% glucose infusion markedly increased the M by
64% and completely restored the impaired Sip to values that
did not differ from those of the virgin control rats, thus
indicating the full reversion of the insulin-resistant
condition.
Insulin responsiveness of mammary gland in late
pregnancy: GUI
As shown above, insulin resistance that normally develops
during late pregnancy disappears in response to a prolonged
hyperinsulinemia caused by the 72 h of 50% glucose infusion.
To investigate insulin responsiveness of mammary gland
during late pregnancy and how this tissue responds to such
prolonged hyperinsulinemic condition, glucose utilization
was quantified by measuring the GUI. GUI was assessed by
the administration of an iv bolus of 2-DOG and the subse-
quent analysis of phosphorylated 2-DOG in the mammary
tissue. These experiments were performed in pregnant and
nonpregnant rats under normoinsulinemia (basal) and under
both short- and long-term hyperinsulinemia, generated by
means of the euglycemic-hyperinsulinemic clamp (1-h HI)
and by the 72-h continuous glucose infusion (72-h HI), re-
spectively. As shown in Fig. 1, in mammary gland of nor-
moglycemic virgin animals (basal), the GUI value was 1.60 6
0.15 mg 3 min21 3 kg21, and neither short-term (1-h HI) nor
prolonged (72-h HI) exposure to hyperinsulinemia affected
the GUI in mammary glands of these animals (1.56 6 0.34 and
1.91 6 0.34 mg 3 min21 3 kg 21, respectively). In pregnant
rats, under basal conditions, the GUI of mammary gland was
TABLE 1. Effect of 50% glucose infusion (35 ml/day) for 3 days in pregnant (day 17–20 of gestation) and virgin rats on body weight and
circulating components
Virgin Pregnant
Control 50% Glucose Control 50% Glucose
Body weight (g) 223 6 6a 209 6 6a 306 6 12b 292 6 6b
Blood glucose (mM) 5.17 6 0.20a 5.52 6 0.37a 4.09 6 0.41b 4.40 6 0.22b
Plasma insulin (pM) 183 6 30a 447 6 32b 465 6 40b 1386 6 83c
In anesthetized Wistar virgin and pregnant rats (at day 17 of gestation), a catheter was placed into the jugular vein. After recovery from
ketamine anesthesia, animals were continuously infused for 3 days (35 ml/day) through the catheter placed in the jugular vein, either with 50%
glucose, to generate sustained hyperinsulinemia, or with bidistilled water (control groups). At the end of the 72-h infusion period, blood samples
(200 ml) were collected to determine glucose and insulin concentrations (21, 22). Values are mean 6 SEM of 6–13 rats/group. Statistical
comparison between groups for each parameter is shown by the superscript letters: different letters indicate significant difference (P , 0.05).
TABLE 2. Effect of sustained hyperinsulinemia-euglycemia on insulin sensitivity in virgin and pregnant rats
Virgin Pregnant
Control 50% Glucose Control 50% Glucose
Blood glucose (mM) 5.60 6 0.20a 5.78 6 0.30a 3.90 6 0.48b 4.43 6 0.18b
Plasma insulin (pM) 1608 6 28a 1920 6 42b 1812 6 48b 2617 6 55c
Glucose disposal rate (M) (gzmin21zkg21) 23.2 6 0.8a 14.3 6 0.8b 9.4 6 0.1c 15.4 6 0.1b
Insulin sensitivity index (Sip) (10
24zdlzmin21zkg21zU21zml) 9.05 6 0.59a 5.16 6 0.29b 4.94 6 0.29b 9.30 6 0.84a
Virgin and pregnant rats were infused with 50% glucose for 72 h (35 ml/day) to generate sustained hyperinsulinemia. Control animals were
infused with bidistilled water. Following the 3-day infusion period, animals were subjected to the euglycemic clamp. A catheter placed in the
jugular vein was connected to a two-way interconnector that received flow from two different infusion pumps. Insulin was infused by means
of one pump at a constant rate of 16 ml/min (0.8 IU 3 h21 3 kg21) for 60 min. Glucose infusion (20%) was given at a variable rate through the
other pump to maintain the blood glucose concentration constant at basal levels. Steady-state glucose infusion was achieved within 30 min of
the clamp. After 60 min, blood samples (200 ml) were collected to determine glucose and insulin concentrations (21, 22). The glucose disposal
rate (M) was calculated as the rate of glucose infusion normalized to body weight, and the insulin sensitivity index (Sip) measured as described
(19, 23). Values are mean 6 SEM of five rats per group. Statistical comparisons for each parameter were made by ANOVA, followed by a Tuckey
test with 95% confidence limits. Significance is shown by superscript letters: different letters indicate significant differences (P , 0.05).
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1.31 6 0.26 mg 3 min21 3 kg 21 and, thus, did not differ from
the value found in the virgin basal group. However, in con-
trast to virgin rats, mammary glands of pregnant animals
responded to hyperinsulinemia with increased glucose uti-
lization (Fig. 1). This effect seemed to be dependent on the
duration of hyperinsulinemia, with GUI values increasing to
2.08 6 0.15 mg 3 min21 3 kg21 (1.6-fold) and to 3.08 6 0.35
mg 3 min21 3 kg21 (2.4-fold) upon exposure to hyperin-
sulinemic conditions for 1 and 72 h, respectively.
Insulin binding characteristics of insulin receptors from
mammary gland
To investigate whether the increased insulin sensitivity of
mammary gland in late pregnancy can be accounted for by
changes in binding of insulin to its receptor, we performed
competition binding studies with 125I-labeled insulin and
insulin receptors partially purified from mammary glands of
virgin and pregnant rats exposed to normo- and hyperin-
sulinemic conditions (i.e. infusion of bidistilled water or 50%
glucose for 72 h, respectively). Scatchard analysis of com-
petition binding curves (not shown) revealed that virgin and
pregnant rats exhibited both low- and high-affinity sites for
insulin. As shown in Table 3, both binding capacity and
affinity of insulin receptors were similar in mammary gland
of pregnant and virgin rats. The binding data also show that
in virgin and pregnant animals, hyperinsulinemia caused by
the 50% glucose infusion did not significantly modify either
maximal insulin binding to both the high-(Bmax-1, ANOVA
P 5 0.68) and low-affinity (B max-2, ANOVA P 5 0.08) re-
ceptor or the affinity of insulin for the high-(Kd-1, ANOVA
P 5 0.761) or for the low-affinity binding sites (Kd-2, ANOVA
P 5 0.203) (Table 3). Furthermore, the number of receptors
per mg of tissue was not significantly affected either by
pregnancy or by sustained hyperinsulinemia (ANOVA P 5
0.177).
Kinase activity of insulin receptor from mammary gland
Because the binding data did not provide an explanation
for the development of increased insulin sensitivity in the
mammary gland during late pregnancy, we speculated that
pregnancy might modify the kinase activity of the mammary
gland insulin receptor. To address this issue, in vitro phos-
phorylation studies, with insulin receptors partially purified
from mammary glands of control and glucose-infused virgin
and pregnant rats, were performed; and the kinase activity
of the receptor was determined as insulin-dependent auto-
phosphorylation of its 95 kDa a-subunit. Representative au-
FIG. 1. Effect of hyperinsulinemia (HI) on glucose utilization in the
mammary gland of virgin and pregnant rats. GUI in mammary gland
of virgin and 20-day-pregnant rats was measured as described in
Materials and Methods under normoglycemic, short-term, and long-
term hyperinsulinemic conditions, i.e. in rats at the end of a 72-h
infusion with bidistilled water (basal group), after 1 h of an eugly-
cemic-hyperinsulinemic clamp (0.8 IU insulin 3 h21 3 kg21), subse-
quent to a 72-h infusion with bidistilled water (1-h HI) or at the end
of a 72-h infusion with 50% glucose [72 h hyperinsulinemic group
(72-h HI)], respectively. Statistical comparisons were made by
ANOVA, followed by a Tuckey test with 95% confidence limits. Sig-
nificance is shown by letters: different letters indicate significant dif-
ference (P , 0.05). Capital letters are used for the pregnant rats.
TABLE 3. Effect of 50% glucose infusion (35 ml/day) for 3 days on insulin binding to the mammary gland insulin receptor of virgin and
pregnant rats
Virgin Pregnant
Control 50% Glucose Control 50% Glucose
Maximal insulin binding (pg of insulin bound/mg protein)
High-affinity (Bmax-1) 18 6 10 55 6 33 53 6 21 37 6 12
Low-affinity (Bmax-2) 8428 6 2699 7296 6 1874 4254 6 1600 1358 6 296
Binding affinity -Kd (nM)
High-affinity (Kd-1) 1.36 6 0.92 0.51 6 0.22 1.40 6 0.70 1.18 6 0.38
Low-affinity (Kd-2) 210 6 40 680 6 170 800 6 260 810 6 170
Receptor number (31026 sites/mg tissue) 5.4 6 1.7 3.6 6 0.7 3.4 6 1.5 1.5 6 0.3
Virgin and pregnant rats were infused with 50% glucose for 72 h (35 ml/day) to generate sustained hyperinsulinemia. Control animals were
infused with bidistilled water. Following the 3-day infusion period, animals were killed and mammary glands rapidly dissected. Insulin receptors
were partially purified as described in the Materials and Methods section. Receptor preparations (10 ml), were incubated overnight with
125I-insulin (100 pM) and increasing concentrations of unlabeled insulin (0.16–1600 nM). Hormone-receptor complexes were separated from free
insulin by 10% polyethylene glycol precipitation. Bmax (maximal insulin binding) and Kd (dissociation constant) for both high- and low-affinity
sites were derived from Scatchard plots with the nonlinear regression fitting option of the Sigma Plot program. Number of receptors per amount
of fresh tissue was determined from the total binding in each experiment. Values are mean 6 SEM of four experiments/group. Statistical
comparisons for each parameter were made by ANOVA with a 95% confidence interval. No significance was found for any of them.
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toradiographs of the phosphorylated and immunoprecipi-
tated mammary gland insulin receptors, in the presence (160
nm) or the absence of insulin, are depicted in the upper part
of Fig. 2. To quantify the kinase activity of the insulin receptor
under the different experimental conditions in each prepa-
ration, 32P-incorporation into the b-subunit was determined
by scanning densitometry and normalized to its insulin bind-
ing activity (IBA). As shown in Fig. 2, insulin receptors from
mammary glands displayed basal autophosphorylation that
was approximately 20-fold higher in pregnant than in virgin
rats. Although, in both groups, autophosphorylation was
markedly increased upon incubation with 160 nm insulin,
phosphorylation levels were always higher in the pregnant
than in the virgin group. The effect of glucose infusion also
was different in virgin and pregnant animals. The quantita-
tive analysis shown in Fig. 2 revealed that in receptors from
mammary gland of glucose-infused virgin rats (i.e. rats kept
hyperinsulinemic for 72 h), insulin (160 nm)-stimulated ki-
nase activity was only 38% of that found in control animals.
Hence, whereas in virgin rats the glucose infusion reduced
the insulin-dependent phosphorylation even more, in preg-
nant rats it led to a slight (although not significant) increase
in insulin-stimulated autophosphorylation. Thus, in the in-
sulin receptors of mammary glands from pregnant rats, the
insulin-stimulated kinase activity was 6- and 20-fold higher
under normo- and hyperinsulinemic conditions, respec-
tively, as compared with virgin animals.
To determine whether pregnancy and/or hyperinsulin-
emia are accompanied by changes in the insulin-responsive-
ness of the kinase activity of the mammary gland insulin
receptor, phosphorylation experiments were carried out in
the presence of increasing concentrations of insulin (0–160
nm), and the degree of autophosphorylation of the receptor
was quantified (by scanning densitometry of the obtained
autoradiographs) and normalized to IBA. The dose-response
curves (Fig. 3) show that the insulin concentrations required
for half-maximal stimulation of receptor autophosphoryla-
tion were virtually identical (ED50 ; 15 nm) under the var-
ious experimental conditions, i.e. virgin and pregnant rats
under control or glucose-infused conditions. These curves
clearly show that the efficacy of insulin to stimulate the
kinase activity of the mammary gland insulin receptor is
markedly higher in pregnant than in virgin rats and that the
highest insulin-dependent phosphorylation was detected in
the glucose-infused pregnant rat group (Fig. 3).
FIG. 2. Insulin receptor (IR) b-subunit autophosphorylation. Insulin
receptors, partially purified from mammary gland, were phosphory-
lated after incubation in the absence or presence (160 nM) of insulin.
Phosphorylated receptors were immunoprecipitated with antiphos-
photyrosine specific antibodies and separated by SDS-PAGE. The
autoradiographs shown in the upper part of the figure identify a
95-kDa band corresponding to the receptor b-subunit. Equal amounts
of WGA-purified protein were used in the four groups. The lower part
of the figure shows the absolute 32P-incorporation into the insulin
receptor. Autoradiographs were quantified by scanning densitometry,
and data were corrected according to the IBA of each preparation.
32Pi-incorporation was expressed as percentage of maximal phos-
phorylation, which was always observed in the presence of 160 nM
insulin, with receptors obtained from glucose-infused pregnant rats.
Data are mean 6 SEM of three experiments.
FIG. 3. Insulin dose-response curves for stimulation of receptor
b-subunit autophosphorylation. Autoradiographs like those in Fig. 2,
but using different insulin concentrations, were quantified by scan-
ning densitometry, and data were corrected according to the IBA of
each preparation. Basal values of phosphorylation are considered 0%.
Curves show the insulin-dependent phosphorylation (above basal),
and data are represented as a percentage of the maximum insulin
effect observed with glucose-infused pregnant-rat receptors. Insulin
concentrations required for half-maximal stimulation (ED50) are
shown by arrows. Values are mean 6 SEM of three experiments. ,
Glucose infused pregnant rats; , pregnant control rats; E, glucose-
infused virgin rats; F, virgin control rats.
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Discussion
The model of the euglycemic-hyperinsulinemic rat, ob-
tained by 50% glucose infusion for 3 days, was used to study
mammary gland insulin sensitivity during pregnancy and to
shed light on the molecular mechanism underlying the re-
sponsiveness of this tissue to insulin. It was found here, in
agreement with previous reports (19), that sustained eugly-
cemia-hyperinsulinemia decreases overall insulin sensitivity
in virgin rats and reverts the insulin resistance condition (19)
normally present in pregnant animals (5, 6, 31, 32). Further-
more, the present study shows, for the first time, that in
pregnant rats, mammary gland displays high insulin-depen-
dent glucose uptake under hyperinsulinemia, caused by ei-
ther the euglycemic-hyperinsulinemic clamp or by the con-
tinuous glucose infusion. In contrast, glucose utilization by
the glands from nonpregnant rats is not affected under the
same conditions. The increased insulin responsiveness in
mammary glands of pregnant rats may be accounted for by
changes in the binding characteristics of the insulin receptor,
by an altered kinase activity and/or phosphorylation status
of the receptor, or by postreceptor events. The data obtained
from radioligand binding studies argue against changes in
the hormone-receptor interaction in late pregnancy or in
response to hyperinsulinemia, because both maximal insulin
binding and affinity to both high- and low-affinity sites re-
main unaffected. These data agree with previous reports (33,
34), showing that the number of insulin receptors expressed
per amount of protein in wheat-germ agglutinin eluates is
similar in mammary gland tissue of untreated virgin and
pregnant rats, without relevant differences in affinity values
between the partially purified insulin receptors from both
groups. Thus, similar to the situation found in liver (29), the
moderate hyperinsulinemia characteristic of pregnancy ap-
parently does not result in a down-regulation of insulin
binding in mammary gland.
In various physiological and pathological situations, in-
sulin resistance has been associated with changes in insulin
receptor function (for review, see Ref. 35) and, more specif-
ically, to an impaired tyrosine kinase activity of the receptor
(for review, see Refs. 36, 28, and 29) or with the existence of
postreceptor defects (12). Supporting the hypothesis that
changes in the insulin receptor kinase activity also may ac-
count for the increased insulin sensitivity of mammary gland
during late pregnancy, it was found here that insulin-in-
duced autophosphorylation of the receptor b-subunit of
pregnant rats was approximately 6-fold higher than in virgin
animals. In addition, basal autophosphorylation of the in-
sulin receptor, determined in the absence of insulin, was also
markedly higher in mammary glands from pregnant rats
than in those from virgin animals. These differences in basal
autophosphorylation may be caused by changes in the re-
ceptor structure or in phosphatase levels. However, this in-
creased basal autophosphorylation does not modify the glu-
cose uptake in the pregnant mammary gland, as compared
with the nonpregnant tissue. Thus, it seems that the differ-
ences in the basal phosphorylation are physiologically irrel-
evant. Dose-response curves confirmed that the concentra-
tion of insulin giving the half-maximal stimulation of
autophosphorylation (ED50 ;15 nm) of the insulin receptor
in mammary gland was similar in the virgin and pregnant
groups. These results indicate that the increased kinase ac-
tivity in pregnant rats is mainly caused by an enhanced
responsiveness to insulin and not to an altered sensitivity to
the hormone.
The hyperinsulinemic condition caused by the prolonged
glucose infusion further impairs insulin stimulation of re-
ceptor b-subunit phosphorylation in virgin rats. Incubation
of adipocytes with high concentrations of glucose has been
reported to inhibit insulin receptor kinase activity (37). Be-
cause adipocytes are the predominant cells in the mammary
gland of virgin rats (14, 15), it may be proposed that, although
glucose homeostasis is maintained during the glucose infu-
sion, the increased availability of glucose might induce an
inhibitory mechanism, impairing insulin receptor autophos-
phorylation in the mammary gland of virgin rats.
It could be argued that the observed differences in insulin
sensitivity of mammary gland between pregnant and virgin
rats are mainly caused by the insulin-sensitive epithelial
cells, which are the major cellular type in the mature gland
of the pregnant rat. However, it is known that lipoprotein
lipase activity is associated with adipose cells in the mature
mammary gland (15, 18) and becomes extremely sensitive to
hyperinsulinemia in both pregnant (17) and lactating rats (10,
38). This, therefore, suggests that the enhanced insulin sen-
sitivity of mammary gland tissue seen in late pregnancy
results from the increased activity of insulin receptors from
both adipose and epithelial cells. Furthermore, because ad-
ipose tissue is one of the most insulin-sensitive tissues, the
absence of insulin response in virgin rat mammary gland
(which is formed mainly by adipose cells) can be explained
only by postulating the existence of mammary gland-specific
mechanisms that inhibit the kinase activity of insulin recep-
tors in virgin, but not in pregnant or lactating, animals.
In conclusion, present findings indicate that, opposite to
the insulin resistance present in most tissues of late-pregnant
rats, mammary glands exhibit increased insulin sensitivity.
Furthermore, we provide evidence that the increased re-
sponse to insulin of the mature mammary gland in late
pregnancy is not accounted for by changes at the level of the
hormone-receptor interaction but by up-regulation of insulin
receptor kinase activity.
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